DTaP-Hib (North American Vaccine)

N/A

Report date: 2025/03/19 20:00:56

Base Information

Drug NameDTaP-Hib (North American Vaccine)

Drug Alias NameCertiva-Hibdiphtheria/tetanus/pertussis/Haemophilus influenzae vaccine (North American Vaccine)

ClassificationVaccines > Biological material > Toxoid vaccineVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Subunit vaccine

Mechanisms of ActionImmunomodulators

TargetsNot applicable

Therapy Area/IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 1 Clinical)

Highest Status in ChinaN/A

Originator CompaniesNorth American Vaccine Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesNorth American Vaccine Inc

Active IndicationsN/A

Inactive IndicationsTetanusDiphtheriaHaemophilus Infections +[4]

Other Information

ATC CodeN/A